We are live on ! Find out more
ISL

Ingalls & Snyder LLC Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.61%
This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$1.95B
AUM Growth
+$108M
Cap. Flow
+$36.7M
Cap. Flow %
1.88%
Top 10 Hldgs %
38.39%
Holding
457
New
17
Increased
108
Reduced
186
Closed
24

Top Buys

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$33.9M
2
CNQ icon
Canadian Natural Resources
CNQ
+$5.27M
3
PXD
Pioneer Natural Resource Co.
PXD
+$4.97M
4
PAAS icon
Pan American Silver
PAAS
+$3.54M
5
OMER icon
Omeros
OMER
+$3.53M

Top Sells

Rank Stock Value
1
CNCE
Concert Pharmaceuticals, Inc.
CNCE
+$7.57M
2
INTC icon
Intel
INTC
+$951K
3
HXL icon
Hexcel
HXL
+$791K
4
NVEI
Nuvei Corporation Subordinate Voting Shares
NVEI
+$777K
5
MSFT icon
Microsoft
MSFT
+$687K

Sector Composition

Rank Sector Weight
1 Healthcare 21.25%
2 Energy 17.15%
3 Technology 13.62%
4 Financials 12.38%
5 Industrials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INTC icon
201
Intel
INTC
$460B
$1.01M 0.05%
31,003
-33,571
-52% -$951K
SMAR
202
DELISTED
Smartsheet Inc.
SMAR
$1M 0.05%
20,928
-1,450
-6% -$63.1K
QQQ icon
203
Invesco QQQ Trust
QQQ
$450B
$996K 0.05%
3,104
+143
+5% +$42.2K
SHEL icon
204
Shell
SHEL
$250B
$986K 0.05%
17,137
– –
TRAK icon
205
ReposiTrak
TRAK
$157M
$984K 0.05%
156,741
-3,075
-2% -$18.3K
GLW icon
206
Corning
GLW
$116B
$983K 0.05%
27,869
+1,711
+7% +$59.5K
GS icon
207
CALL
Goldman Sachs
GS
$302B
$981K 0.05%
3,000
-1,000
-25% -$348K
EG icon
208
Everest Group
EG
$14.9B
$974K 0.05%
2,721
+101
+4% +$36.3K
COST icon
209
Costco
COST
$423B
$967K 0.05%
1,947
+6
+0.3% +$2.94K
GSK icon
210
GSK
GSK
$104B
$966K 0.05%
27,162
+542
+2% +$19K
SNY icon
211
Sanofi
SNY
$103B
$952K 0.05%
17,495
-475
-3% -$23.1K
BG icon
212
Bunge Global
BG
$20.4B
$941K 0.05%
9,851
-106
-1% -$10.3K
WTRG icon
213
Essential Utilities
WTRG
$11.4B
$922K 0.05%
21,122
-22
-0.1% -$992
XLY icon
214
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.9B
$875K 0.05%
11,706
– –
HUBB icon
215
Hubbell
HUBB
$25B
$855K 0.04%
3,515
– –
MU icon
216
Micron Technology
MU
$988B
$825K 0.04%
13,667
-106
-0.8% -$6.21K
TMO icon
217
Thermo Fisher Scientific
TMO
$214B
$813K 0.04%
1,411
+6
+0.4% +$3.38K
BNY
218
Bank of New York Mellon
BNY
$106B
$808K 0.04%
17,784
+388
+2% +$18.8K
D icon
219
Dominion Energy
D
$61.3B
$795K 0.04%
14,215
-567
-4% -$33.2K
ASML icon
220
ASML
ASML
$634B
$791K 0.04%
1,162
-20
-2% -$12.8K
O icon
221
Realty Income
O
$60.1B
$788K 0.04%
12,450
-400
-3% -$25.9K
APPF icon
222
AppFolio
APPF
$6.23B
$780K 0.04%
6,268
-2,750
-30% -$332K
WFC.PRL icon
223
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.69B
$763K 0.04%
649
-28
-4% -$33.7K
HPQ icon
224
CALL
HP
HPQ
$24.6B
$760K 0.04%
25,900
– –
BA icon
225
Boeing
BA
$175B
$758K 0.04%
3,566
+67
+2% +$13.9K
7 8
9
10 11

Similar funds

GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
AF
Aviso Financial Toronto, Ontario, Canada $2.82B AUM 24.96% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
GI
GLOBALT Investments Atlanta, Georgia $2.8B AUM 21.13% 1-Year Est. Return
MWM
Meridian Wealth Management Lexington, Kentucky $2.85B AUM 31.23% 1-Year Est. Return
MSDF
Michael & Susan Dell Foundation New York $2.85B AUM 26.28% 1-Year Est. Return
SHIM
Spruce House Investment Management New York $2.8B AUM 65.68% 1-Year Est. Return

Ingalls & Snyder LLC's Q1 2023 Portfolio in Review

As of Q1 2023, Ingalls & Snyder LLC held 457 positions worth $1.95B, up 5.9% from $1.84B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Ingalls & Snyder LLC's Q1 2023 filing shows 17 new, 108 increased, 186 reduced and 24 closed positions. Its largest new stake was TSMC: 31,331 shares worth $2.91M. The largest sale was Concert Pharmaceuticals, Inc., an estimated $7.57M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Energy and Technology.

  • Ingalls & Snyder LLC's largest Q1 2023 buy was TSMC: 31,331 shares worth $2.91M.
  • Ingalls & Snyder LLC added most to Corcept Therapeutics in Q1 2023, an estimated $33.9M increase.
  • Ingalls & Snyder LLC's biggest Q1 2023 reduction was Intel, cutting an estimated $951K.
  • Ingalls & Snyder LLC fully exited Concert Pharmaceuticals, Inc. in Q1 2023, selling an estimated $7.57M.
  • Ingalls & Snyder LLC's ten largest holdings make up 38% of its $1.95B portfolio in Q1 2023.
  • Ingalls & Snyder LLC opened 17 new positions and closed 24 in Q1 2023.
  • Ingalls & Snyder LLC's portfolio value rose 5.9% quarter-over-quarter to $1.95B.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2023, filed 9 May 2023.